review · Adipocyte

Low circulating levels of neuregulin 4 as a potential biomarker associated with the severity and prognosis of obesity-related metabolic diseases: a systematic review

Khanyisani Ziqubu
Phiwayinkosi V. Dludla
Sinenhlanhla X. H. Mthembu
Bongani B. Nkambule
Sithandiwe E. Mazibuko-Mbeje

20249 citationsOpen accessUniversity of Zululand

Abstract

Current clinical evidence emphasizes that the circulating levels of Nrg4 are decreased in morbid obesity, and it also highlights that Nrg4 May serve as a potential prognostic biomarker for obesity-related metabolic diseases.

Research topics

Liver Disease Diagnosis and Treatment
Diet and metabolism studies
Metabolism, Diabetes, and Cancer

Sustainable Development Goals

Zero Hunger

Read the original research

This page summarises published work. The authoritative version sits with the publisher.

View on publisher site Record on OpenAlex

DOI: 10.1080/21623945.2024.2390833

Is something wrong with this record? Report it or request removal.

Discussion

Discuss this research

Have you built on this work, tried to replicate it, or seen it applied in practice? Share what you know. Verified researchers and MARATTO™ domain experts can open a discussion, and any member can reply. Contributions are reviewed before they appear.

No discussion yet. Open the first thread.

New to MARATTO™? Create a free account.